Aarti Pharmalabs Limited to hold 7th AGM on Sep 22, 2026; sets Sep 15 as record date for final dividend.
Aarti Pharmalabs Limited will hold its 7th AGM on September 22, 2026, via VC/OAVM. The record date for final dividend payment for FY2025-26 is set for September 15, 2026. Newspaper advertisements were published on August 18, 2026.
This is a standard procedural announcement for an upcoming AGM and dividend payment, which typically has a low immediate impact on the stock price.
The announcement is a routine regulatory filing regarding the AGM and dividend record date, with no new financial performance or strategic changes disclosed.
Aarti Pharmalabs Limited has announced that its 7th Annual General Meeting (AGM) will be conducted on Tuesday, September 22, 2026, commencing at 11:00 AM (IST). The meeting will be held through Video Conferencing (VC) or Other Audio Visual Means (OAVM).
The company has also fixed Tuesday, September 15, 2026, as the record date for the payment of the final dividend for the financial year 2025-26. Shareholders who have not yet registered their Email IDs with their depository participants are requested to do so.
The details of the AGM and record date were published in newspaper advertisements in the Financial Express (English) and Loksatta – Jansatta (Gujarati) on Tuesday, August 18, 2026. The advertisement is also available on the company's website.
What to do with a filing like this
Aarti Pharmalabs Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Pharmalabs Limited. Read the original for the full detail.